The experts comprised 16 practicing physicians from Belgium, Denmark, Finland, The Netherlands, Norway, and Sweden. Each was selected for their experience in managing patients with asthma and/or CRS. Also considered was their involvement in scientific meetings, guidelines, and education, and publications records. Selection ensured a variety of care models, and equal numbers of pulmonologists and ENT physicians/rhinologists—including those also specialized in allergology—were represented.
The expert group was led by a Steering Committee of eight individuals with at least one member from each country, and co-chaired by one pulmonologist and one ENT physician. The Steering Committee guided the project's scope and provided clinical leadership.
To ensure the suggestions arising from the experts’ discussions were relevant to patients’ and primary care concerns, the all-expert meeting was joined by a practicing GP from Norway, and a patient from Finland with severe asthma and CRS.
For the purposes of this initiative, CRSwNP was defined as per the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) 2020 guidelines (44 (link)).
The expert group was led by a Steering Committee of eight individuals with at least one member from each country, and co-chaired by one pulmonologist and one ENT physician. The Steering Committee guided the project's scope and provided clinical leadership.
To ensure the suggestions arising from the experts’ discussions were relevant to patients’ and primary care concerns, the all-expert meeting was joined by a practicing GP from Norway, and a patient from Finland with severe asthma and CRS.
For the purposes of this initiative, CRSwNP was defined as per the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) 2020 guidelines (44 (link)).
Free full text: Click here
